Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review

Journal of the American Academy of Dermatology

Volumn 75, Issue 4, 2016, Pages 806-812.e3

  Liu, Lucy Y ^a   King, Brett A ^a   Craiglow, Brittany G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

alopecia areata; alopecia totalis; alopecia universalis; health related quality of life; quality of life; review

Indexed keywords

ALOPECIA AREATA; ATOPIC DERMATITIS; DISEASE SEVERITY; HUMAN; MENTAL HEALTH; PRIORITY JOURNAL; PSORIASIS; PSYCHOLOGICAL WELL-BEING; QUALITY OF LIFE; QUALITY OF LIFE INDEX; REVIEW; SYSTEMATIC REVIEW; ADAPTIVE BEHAVIOR; ADOLESCENT; ADULT; AGE; CASE CONTROL STUDY; FEMALE; MALE; MIDDLE AGED; PSYCHOLOGY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; SICKNESS IMPACT PROFILE; YOUNG ADULT;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGE FACTORS; ALOPECIA AREATA; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SICKNESS IMPACT PROFILE; YOUNG ADULT;

EID: 84995549335     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2016.04.035     Document Type: Review

References (43)

1. 1 Mirzoyev, S.A., Schrum, A.G., Davis, M.D., Torgerson, R.R., Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009. J Invest Dermatol 134 (2014), 1141–1142.
2. 2 Gilhar, A., Kalish, R.S., Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev 5 (2006), 64–69.
3. 3 Ito, T., Tokura, Y., The role of cytokines and chemokines in the T-cell-mediated autoimmune process in alopecia areata. Exp Dermatol 23 (2014), 787–791.
4. 4 Xing, L., Dai, Z., Jabbari, A., et al. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat Med 20 (2014), 1043–1049.
5. 5 Martinez-Mir, A., Zlotogorski, A., Ott, J., Gordon, D., Christiano, A.M., Genetic linkage studies in alopecia areata. J Invest Dermatol Symp Proc 8 (2003), 199–203.
6. 6 Green, J., Sinclair, R.D., Genetics of alopecia areata. Australas J Dermatol 41 (2000), 213–218.
7. 7 Martinez-Mir, A., Zlotogorski, A., Gordon, D., et al. Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata. Am J Hum Genet 80 (2007), 316–328.
8. 8 Islam, N., Leung, P.S., Huntley, A.C., Gershwin, M.E., The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev 14 (2015), 81–89.
9. 9 MacLean, K.J., Tidman, M.J., Alopecia areata: more than skin deep. Practitioner 257 (2013), 29–32 3.
10. 10 Craiglow, B.G., King, B.A., Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis. J Invest Dermatol 134 (2014), 2988–2990.
11. 11 Prickitt, J., McMichael, A.J., Gallagher, L., Kalabokes, V., Boeck, C., Helping patients cope with chronic alopecia areata. Dermatol Nurs 16 (2004), 237–241.
12. 12 Grahovac, T., Ruzic, K., Sepic-Grahovac, D., Dadic-Hero, E., Radonja, A.P., Depressive disorder and alopecia. Psychiatr Danub 22 (2010), 293–295.
13. 13 Ghanizadeh, A., Comorbidity of psychiatric disorders in children and adolescents with alopecia areata in a child and adolescent psychiatry clinical sample. Int J Dermatol 47 (2008), 1118–1120.
14. 14 Liakopoulou, M., Alifieraki, T., Katideniou, A., et al. Children with alopecia areata: psychiatric symptomatology and life events. J Am Acad Child Adolesc Psychiatry 36 (1997), 678–684.
15. 15 Aghaei, S., Saki, N., Daneshmand, E., Kardeh, B., Prevalence of psychological disorders in patients with alopecia areata in comparison with normal subjects. ISRN Dermatol, 2014, 2014, 304370.
16. 16 World Health Organization, WHOQoL study protocol: the development of the World Health Organization quality of life assessment instrument. 1993, World Health Organization, Geneva.
17. 17 Patrick, D.L., Bush, J.W., Chen, M.M., Methods for measuring levels of well-being for a health status index. Health Serv Res 8 (1973), 228–245.
18. 18 Finlay, A.Y., Khan, G.K., Dermatology Life Quality Index (DLQI)–a simple practical measure for routine clinical use. Clin Exp Dermatol 19 (1994), 210–216.
19. 19 Chren, M.-M., Lasek, R., Sahay, A., Sands, L., Measurement properties of skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg 5 (2001), 105–110.
20. 20 Ware, J.E. Jr., Sherbourne, C.D., The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992), 473–483.
21. 21 Bilgiç, Ö., Bilgiç, A., Bahalı, K., Bahali, A.G., Gürkan, A., Yılmaz, S., Psychiatric symptomatology and health-related quality of life in children and adolescents with alopecia areata. J Eur Acad Dermatol Venereol 28 (2014), 1463–1468.
22. 22 Shi, Q., Duvic, M., Osei, J.S., et al. Health-related quality of life (HRQoL) in alopecia areata patients – a secondary analysis of the National Alopecia Areata Registry Data. J Investig Dermatol Symp Proc 16 (2013), S49–S50.
23. 23 Ghajarzadeh, M., Ghiasi, M., Kheirkhah, S., Associations between skin diseases and quality of life: a comparison of psoriasis, vitiligo, and alopecia areata. Acta Med Iran 50 (2012), 511–515.
24. 24 Gulec, A.T., Tanriverdi, N., Duru, C., Saray, Y., Akcali, C., The role of psychological factors in alopecia areata and the impact of the disease on the quality of life. Int J Dermatol 43 (2004), 352–356.
25. 25 Dubois, M., Baumstarck-Barrau, K., Gaudy-Marqueste, C., et al. Quality of life in alopecia areata: a study of 60 cases. J Invest Dermatol 130 (2010), 2830–2833.
26. 26 Reid, E.E., Haley, A.C., Borovicka, J.H., et al. Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia. J Am Acad Dermatol 66 (2012), e97–e102.
27. 27 Masmoudi, J., Sellami, R., Ouali, U., et al. Quality of life in alopecia areata: a sample of Tunisian patients. Dermatol Res Pract, 2013, 2013, 983804.
28. 28 de Hollanda, T.R., Sodre, C.T., Brasil, M.A., Ramos, E.S.M., Quality of life in alopecia areata: a case-control study. Int J Trichology 6 (2014), 8–12.
29. 29 Jankovic, S., Peric, J., Maksimovic, N., et al. Quality of life in patients with alopecia areata: a hospital-based cross-sectional study. J Eur Acad Dermatol Venereol 30:5 (2016), 840–846.
30. 30 Al-Mutairi, N., Eldin, O.N., Clinical profile and impact on quality of life: seven years experience with patients of alopecia areata. Indian J Dermatol Venereol Leprol 77 (2011), 489–493.
31. 31 Qi, S., Xu, F., Sheng, Y., Yang, Q., Assessing quality of life in alopecia areata patients in China. Psychol Health Med 20 (2015), 97–102.
32. 32 Williamson, D., Gonzalez, M., Finlay, A.Y., The effect of hair loss on quality of life. J Eur Acad Dermatol Venereol 15 (2001), 137–139.
33. 33 Sojevic Timotijevic, Z., Jankovic, S., Trajkovic, G., et al. Identification of psoriatic patients at risk of high quality of life impairment. J Dermatol 40 (2013), 797–804.
34. 34 Beikert, F.C., Langenbruch, A.K., Radtke, M.A., Augustin, M., Willingness to pay and quality of life in patients with rosacea. J Eur Acad Dermatol Venereol 27 (2013), 734–738.
35. 35 Chernyshov, P.V., Health related quality of life in adult atopic dermatitis and psoriatic patients matched by disease severity. Ital J Dermatol Venereol, 2014.
36. 36 Lundberg, L., Johannesson, M., Silverdahl, M., Hermansson, C., Lindberg, M., Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol 80 (2000), 430–434.
37. 37 Beikert, F.C., Langenbruch, A.K., Radtke, M.A., Kornek, T., Purwins, S., Augustin, M., Willingness to pay and quality of life in patients with atopic dermatitis. Arch Dermatol Res 306 (2014), 279–286.
38. 38 Chiang, Y.Z., Bundy, C., Griffiths, C.E., Paus, R., Harries, M.J., The role of beliefs: lessons from a pilot study on illness perception, psychological distress and quality of life in patients with primary cicatricial alopecia. Br J Dermatol 172 (2015), 130–137.
39. 39 Colon, E.A., Popkin, M.K., Callies, A.L., Dessert, N.J., Hordinsky, M.K., Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Compr Psychiatry 32 (1991), 245–251.
40. 40 Karimkhani, C., Boyers, L.N., Prescott, L., et al. Global burden of skin disease as reflected in Cochrane Database of Systematic Reviews. JAMA Dermatol 150 (2014), 945–951.
41. 41 Hagstrom, E.L., Patel, S., Karimkhani, C., et al. Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden. J Am Acad Dermatol 73 (2015), 383–391.e1.
42. 42 Olsen, E., Hordinsky, M., McDonald-Hull, S., et al. Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation. J Am Acad Dermatol 40 (1999), 242–246.
43. 43 Varni, J.W., Seid, M., Rode, C.A., The PedsQL: measurement model for the pediatric quality of life inventory. Medical Care 37 (1999), 126–139.